公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | Genome-wide DNA hypermethylation and homocysteine increase a risk for myopia | Hsi, Edward; YUNG-SONG WANG ; Huang, Chia-Wei; Yu, Ming-Lung; Juo, Suh-Hang Hank; Liang, Chung-Ling | International Journal of Ophthalmology | | | |
2024 | Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease | Younossi, Zobair M; Alqahtani, Saleh A; Alswat, Khalid; Yilmaz, Yusuf; Keklikkiran, Caglayan; Funuyet-Salas, Jesús; Romero-Gómez, Manuel; Fan, Jian-Gao; Zheng, Ming-Hua; El-Kassas, Mohamed; Castera, Laurent; CHUN-JEN LIU ; Wai-Sun Wong, Vincent; Zelber-Sagi, Shira; Allen, Alina M; Lam, Brian; Treeprasertsuk, Sombat; Hameed, Saeed; Takahashi, Hirokazu; Kawaguchi, Takumi; Schattenberg, Jörn M; Duseja, Ajay; Newsome, Phil N; Francque, Sven; Spearman, C Wendy; Castellanos Fernández, Marlen I; Burra, Patrizia; Roberts, Stuart K; Chan, Wah-Kheong; Arrese, Marco; Silva, Marcelo; Rinella, Mary; Singal, Ashwani K; Gordon, Stuart; Fuchs, Michael; Alkhouri, Naim; Cusi, Kenneth; Loomba, Rohit; Ranagan, Jane; Eskridge, Wayne; Kautz, Achim; Ong, Janus P; Kugelmas, Marcelo; Eguchi, Yuichiro; Diago, Moises; Yu, Ming-Lung; Gerber, Lynn; Fornaresio, Lisa; Nader, Fatema; Henry, Linda; Racila, Andrei; Golabi, Pegah; Stepanova, Maria; Carrieri, Patrizia; Lazarus, Jeffrey V | Journal of hepatology | 10 | 0 | |
2009 | Hbsag Clearance Continues to Increase Post-Treatment in Patients with Hcv Hbv Coinfection Treated with Peginterferon Alfa-2a Plus Ribavirin: 1.5 Year Follow-Up | LIU, CHUN-JEN; WU, SHUN-SHENG; CHAO, YOU- CHEN; YANG, SIEN-SING; LIN, CHIH-LIN; KAO, JIA-HORNG; LIU, CHEN-HUA; CHEN, PEI-JER; CHEN, DING-SHINN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN | HEPATOLOGY | | | |
2023 | HCV Microelimination for High-risk Special Populations | Huang, Chung-Feng; Chen, Guan-Jhou; CHIEN-CHING HUNG ; Yu, Ming-Lung | The Journal of infectious diseases | 5 | 0 | |
2012 | Improvement of Nonalcoholic Fatty Liver Disease After Bariatric Surgery in Morbidly Obese Chinese Patients | Tai, Chi-Ming; Huang, Chih-Kun; Hwang, Jau-Chung; Chiang, Hung; Chang, Chi-Yang; Lee, Ching-Tai; Yu, Ming-Lung; Lin, Jaw-Town | Obesity Surgery | 73 | 67 | |
2014 | Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials | Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng | Hepatology | | | |
2023 | Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan | Tsai, Pei-Chien; Kuo, Hsing-Tao; Hung, Chao-Hung; Tseng, Kuo-Chih; Lai, Hsueh-Chou; Peng, Cheng-Yuan; Wang, Jing-Houng; Chen, Jyh-Jou; Lee, Pei-Lun; Chien, Rong-Nan; Yang, Chi-Chieh; Lo, Gin-Ho; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan, Sheng-Lei; Bair, Ming-Jong; Lin, Chun-Yen; Su, Wei-Wen; Chu, Cheng-Hsin; Chen, Chih-Jen; Tung, Shui-Yi; Tai, Chi-Ming; Lin, Chih-Wen; Lo, Ching-Chu; Cheng, Pin-Nan; Chiu, Yen-Cheng; Wang, Chia-Chi; Cheng, Jin-Shiung; Tsai, Wei-Lun; Lin, Han-Chieh; Huang, Yi-Hsiang; Yeh, Ming-Lun; Huang, Chung-Feng; Hsieh, Meng-Hsuan; Huang, Jee-Fu; Dai, Chia-Yen; Chung, Wan-Long; Chen, Chi-Yi; Yu, Ming-Lung | Journal of hepatology | 16 | 8 | |
2022 | NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression | Wang, Ya-Chin; Tsai, Ming-Chao; Chen, Yaw-Sen; Hsieh, Pei-Min; Hung, Chao-Ming; Lin, Hung-Yu; Hsu, Yao-Chun; Yeh, Jen-Hao; Hsiao, Pojen; Su, Yu-Cheih; Ma, Ching-Hou; CHIH-YUAN LEE ; Lin, Chih-Che; Shu, Chih-Wen; Li, Yu-Chan; Tsai, Mei-Hsing; Lin, James Yu; Peng, Wei-Hao; Yu, Ming-Lung; Lin, Chih-Wen | Hepatology communications | 2 | 1 | |
2015 | Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 8 | 8 | |
2015 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 7 | 7 | |
2013 | Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO | Annals of internal medicine | 85 | 77 | |
2022 | Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations | HSIN-YUN SUN ; WANG-DA LIU ; Wang, Chih-Wen; Wei, Yu-Ju; KUAN-YIN LIN ; YU-SHAN HUANG ; Su, Li-Hsin; YI-TING CHEN ; Liu, Wen-Chun; Su, Yi-Chin; Chen, Yea-Wen; YU-CHUNG CHUANG ; Lu, Po-Liang; CHIEN-CHING HUNG ; Yu, Ming-Lung | Microbiology Spectrum | 8 | 4 | |
1998 | PREVALENCE AND MANIFESTATIONS OF HEPATITIS C SEROPOSITIVITY IN CHILDREN IN AN ENDEMIC AREA | LU, SHENG-NAN; CHEN, HUI-CHI; WU, MEI-HUEI; YU, MING-LUNG; CHUANG, WAN-LONG; LU, CHIH-FENG; CHANG, WEN-YU; CHEN, CHIEN-JEN | PEDIATRIC INFECTIOUS DISEASE JOURNAL | | | |
2012 | Profiles and Clinical Significance of HBsAg Titer in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses | Liu, Chun-Jen; Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Wu, Shun-Sheng; Yang, Sien-Sing; Kao, Jia-Horng; Lin, Chih-Lin; Chen, Pei-Jer; Chen, Ding-Shinn | Hepatology | | | |
2021 | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Teng, Wei; Chang, Ting-Tsung; Yang, Hwai-I; Peng, Cheng-Yuan; Su, Chien-Wei; TUNG-HUNG SU ; Hu, Tsung-Hui; Yu, Ming-Lung; HUNG-CHIH YANG ; Wu, Jaw-Ching | Hepatology international | 15 | 11 | |
2021 | Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C | SHIH-JER HSU ; Yu, Ming-Lung; Su, Chien-Wei; Peng, Cheng-Yuan; Chien, Rong-Nan; Lin, Hsien-Hong; Lo, Gin-Ho; Su, Wei-Wen; Kuo, Hsing-Tao; Hsu, Chao-Wei; Yang, Sien-Sing; Yang, Sheng-Shun; Tseng, Kuan-Chiao; Qin, Albert; Huang, Yi-Wen; Chuang, Wan-Long | Journal of the Formosan Medical Association = Taiwan yi zhi | 14 | 12 | |
2014 | Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study | Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen | Hepatology | | | |
2014 | Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study | Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen | Hepatology | | | |
2024 | Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases | Cheng, Pin-Nan; WEN-JONE CHEN ; Hou, Charles Jia-Yin; Lin, Chih-Lin; Chang, Ming-Ling; Wang, Chia-Chi; Chang, Wei-Ting; Wang, Chao-Yung; Lin, Chun-Yen; Hung, Chung-Lieh; Peng, Cheng-Yuan; Yu, Ming-Lung; Chao, Ting-Hsing; Huang, Jee-Fu; Huang, Yi-Hsiang; Chen, Chi-Yi; Chiang, Chern-En; Lin, Han-Chieh; Li, Yi-Heng; TSUNG-HSIEN LIN ; JIA-HORNG KAO ; TZUNG-DAU WANG ; Liu, Ping-Yen; YEN-WEN WU ; CHUN-JEN LIU | Clinical and molecular hepatology | 1 | | |
2023 | TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes | Yu, Ming-Lung; CHIH-YUAN WANG ; Lee, Mei-Hsuan; Ou, Horng-Yih; Cheng, Pin-Nan; Tu, Shih-Te; Huang, Jee-Fu; Chen, Jung-Fu; Hu, Tsung-Hui; Hsu, Chih-Cheng; JIA-HORNG KAO ; Chen, Chien-Jen; Lin, Han-Chieh; Huang, Chien-Ning | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 2 | |